Novo Nordisk A/S ADR (NVO) News

Novo Nordisk A/S ADR (NVO): $124.51

0.89 (-0.71%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

B

Filter NVO News Items

NVO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

NVO News Highlights

  • For NVO, its 30 day story count is now at 24.
  • Over the past 27 days, the trend for NVO's stories per day has been choppy and unclear. It has oscillated between 1 and 6.
  • The most mentioned tickers in articles about NVO are DRUG, JAZZ and TOP.

Latest NVO News From Around the Web

Below are the latest news stories about NOVO NORDISK A S that investors may wish to consider to help them evaluate NVO as an investment opportunity.

2024’s Power Players: 7 Stocks Racing to a Trillion Valuation

Whether in 2024, or in the years ahead, each of these seven stocks could become the next trillion dollar companies.

Thomas Niel on InvestorPlace | January 1, 2024

3 Ken Griffin Stocks to Invest Like Citadel

Invest like Citadel founder and billionaire Ken Griffin with these stocks that have strong potential heading into 2024.

Alex Sirois on InvestorPlace | December 30, 2023

The Zacks Analyst Blog Highlights Novo Nordisk, Walmart, Advanced Micro Devices, Caterpillar and Union Pacific

Novo Nordisk, Walmart, Advanced Micro Devices, Caterpillar and Union Pacific are part of the Zacks top Analyst Blog.

Yahoo | December 28, 2023

Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague.

While Novo Nordisk dominates the weight-loss market, there are two other stocks to consider as well.

Yahoo | December 28, 2023

Novo Nordisk (NVO) Rose on Increased Demand

ClearBridge Investments, an investment management company, released its “ClearBridge Sustainability Leaders Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy underperformed its benchmark, the Russell 3000 Index, in the quarter. The strategy gained two out of 10 sectors in which it invested during the quarter, on an absolute […]

Yahoo | December 28, 2023

Top Analyst Reports for Novo Nordisk, Walmart & AMD

Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Walmart Inc. (WMT) and Advanced Micro Devices, Inc. (AMD).

Yahoo | December 27, 2023

TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Poised to Perform in 2024

In just a few days, we’ll celebrate a new year, with a short break to watch the Old Year out and the New Year in, ending a marathon run of holidays that started with Thanksgiving. It’s a time to gather with family, catch our breath, and get ready to plunge back into the day-to-day business of ordinary life. And for stock traders, that means finding the best stocks to add to a profitable investment portfolio. The markets put up a massive wall of raw data, all the information generated by thousand

Yahoo | December 27, 2023

Healthcare Stocks Had a Terrible 2023. Things Are Looking Up.

Things could hardly have gone worse for healthcare investors in 2023. Goldman Sachs analysts called the gap at mid December, with health care stocks down nearly 2% and the S&P 500 up more than 205, the sector’s “most significant annual underperformance in 30 years.” The healthcare sector typically underperforms the broader market in general election years, as presidential hopefuls pledge to reform drug prices or health insurance,  spooking investors into a selloff.

Yahoo | December 27, 2023

Sarepta (SRPT) Seeks Label Expansion for DMD Gene Therapy

Sarepta (SRPT) files a supplement with the FDA seeking to expand its recently-approved gene therapy Elevidys' label to treat all DMD patients, regardless of age and ambulatory status.

Yahoo | December 26, 2023

Will Novo Nordisk Be Worth More Than Meta Platforms by 2030?

The gap in market cap between these two companies is big today, but it could shrink in the future.

Yahoo | December 23, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!